Sign Up

About ARALAST NP Therapy

ARALAST NP ARALAST NP

Conferences

Event Location Date
AANP 25th National Conference
American Academy of Nurse Practitioners (AANP)
Phoenix, AZ June 23 – 27, 2010
AARC Summer Forum
American Association of Respiratory Care (AARC)
Marco Island, FL July 16 – 18, 2010
AACVPR 25th Annual Meeting
American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR)
Milwaukee, WI October 7 – 9, 2010
CHEST 2010
American College of Chest Physicians (ACCP)
Vancouver, BC, Canada October 30 – November 4, 2010
International Respiratory Congresses
American Association of Respiratory Care (AARC)
Las Vegas, NV December 6 – 9, 2010

To learn about events of interest to Alphas and their families, visit Community Events.

ARALAST NP [Alpha1-Proteinase Inhibitor (Human)]

ARALAST NP is indicated for chronic augmentation therapy in patients having congenital deficiency of A1-PI with clinically evident emphysema. ARALAST NP is not indicated as therapy for lung disease patients in whom congenital A1-PI deficiency has not been established.

The effect of augmentation therapy with ARALAST NP on pulmonary exacerbations and on the progression of emphysema in alpha1-antitrypsin deficiency has not been demonstrated in randomized, controlled clinical trials.

Please review the Important Risk Information and the Full Prescribing Information

Please review the Important Risk Information and the Full Prescribing Information